Advertisement
Screener

GE HEALTHCARE TECHNOLOGIES INC. (GEHC) Overview

GE HEALTHCARE TECHNOLOGIES INC. (GEHC) Overview

  • 1 Jan 2026: Period ending 31 Mar 2026; Estimate (m); Actual 0.85; Beat / miss (m).
  • 1 Jul 2025: Period ending 30 Sept 2025; Estimate (m); Actual 0.98; Beat / miss (m).
  • 1 Apr 2025: Period ending 30 Jun 2025; Estimate (m); Actual 1.06; Beat / miss (m).
  • 1 Jan 2025: Period ending 31 Mar 2025; Estimate (m); Actual 1.23; Beat / miss (m).

Stock Price Chart

View more →

Blue: Split-adjusted close · Orange: Cumulative dividend-reinvested close

$56.52$62.38$68.85$75.99$83.88$92.582025-11-062026-11-06$53.20$60.21$68.14$77.12$87.28$98.772022-12-152026-11-06$53.20$60.21$68.14$77.12$87.28$98.772022-12-152026-11-06$53.20$60.21$68.14$77.12$87.28$98.772022-12-152026-11-06$53.20$60.21$68.14$77.12$87.28$98.772022-12-152026-11-06

Logarithmic scale. Both lines share the same starting value for the selected range.

Last close
$82.38
Previous close
$66.46
Change
$15.92
Change (%)
23.95%
Close date
2026-11-06
Previous close date
2026-09-29
Open
(m)
Day high
(m)
Day low
(m)
Last session volume
(m)
Last session value
(m)
Currency
USD
Price basis
split-adjusted
Volume basis
(m)

Performance

View more →

Cumulative total returns · 2026-09-29

YTD

GEHC
-18.82%
S&P 500
(m)

1 year

GEHC
-8.87%
S&P 500
(m)

3 years

GEHC
-1.78%
S&P 500
(m)

5 years

GEHC
(m)
S&P 500
(m)

Earnings trends

View more →

Earnings per share

USD / share · As filed

31 Mar 2026 ○ Estimate (m) ● Actual 0.85

0.770.931.091.251.4130 Sept 2024: estimate (m); actual 1.0230 Sept 2024(m)31 Mar 2025: estimate (m); actual 1.2331 Mar 2025(m)30 Jun 2025: estimate (m); actual 1.0630 Jun 2025(m)30 Sept 2025: estimate (m); actual 0.9830 Sept 2025(m)31 Mar 2026: estimate (m); actual 0.8531 Mar 2026(m)
Comparison details
Period startPeriod endingEstimateActualBeat / missReport date
1 Jan 202631 Mar 2026(m)0.85(m)(m)
1 Jul 202530 Sept 2025(m)0.98(m)(m)
1 Apr 202530 Jun 2025(m)1.06(m)(m)
1 Jan 202531 Mar 2025(m)1.23(m)(m)
1 Jul 202430 Sept 2024(m)1.02(m)(m)

31 Dec 2025 ○ Estimate (m) ● Actual 4.55

2.953.494.044.585.1331 Dec 2021: estimate (m); actual 4.9531 Dec 2021(m)31 Dec 2022: estimate (m); actual 4.2231 Dec 2022(m)31 Dec 2023: estimate (m); actual 3.0331 Dec 2023(m)31 Dec 2024: estimate (m); actual 4.3431 Dec 2024(m)31 Dec 2025: estimate (m); actual 4.5531 Dec 2025(m)
Comparison details
Period startPeriod endingEstimateActualBeat / missReport date
1 Jan 202531 Dec 2025(m)4.55(m)(m)
1 Jan 202431 Dec 2024(m)4.34(m)(m)
1 Jan 202331 Dec 2023(m)3.03(m)(m)
1 Jan 202231 Dec 2022(m)4.22(m)(m)
1 Jan 202131 Dec 2021(m)4.95(m)(m)

Revenue vs. Earnings

USD

31 Mar 2026 ■ Revenue 5.13B ■ Earnings 0.39B — Profit margin 7.58%

-0.68B6.6%1.67B8.2%4.03B9.8%6.38B11.3%30 Jun 2025: revenue 5.01B; earnings 0.49B; profit margin 9.71%30 Jun 202530 Sept 2025: revenue 5.14B; earnings 0.45B; profit margin 8.67%30 Sept 202531 Dec 2025: revenue 5.70B*; earnings 0.59B*; profit margin 10.34%*; Revenue: Annual amount − nine-month amount; Earnings: Annual amount − nine-month amount; period 2025-10-01 to 2025-12-31; USD.31 Dec 202531 Mar 2026: revenue 5.13B; earnings 0.39B; profit margin 7.58%31 Mar 2026

31 Dec 2025 ■ Revenue 20.63B ■ Earnings 2.08B — Profit margin 10.10%

-2.48B7.0%6.05B8.5%14.57B10.0%23.10B11.4%31 Dec 2022: revenue 18.34B; earnings 1.92B; profit margin 10.45%31 Dec 202231 Dec 2023: revenue 19.55B; earnings 1.57B; profit margin 8.02%31 Dec 202331 Dec 2024: revenue 19.67B; earnings 1.99B; profit margin 10.13%31 Dec 202431 Dec 2025: revenue 20.63B; earnings 2.08B; profit margin 10.10%31 Dec 2025

Analyst insights

View more →
RatingsBuyHoldSellOther ratingsLast CloseAverage TargetUpsideHigh TargetLow Target
(m)(m)(m)(m)(m)$82.38(m)(m)(m)(m)
Past 12 Months12 Month ForecastLast Close$82.38High(m)Average(m)Low(m)2025-11-062026-11-06

Recent news

View more →

(m)

YouTube videos mentioning GEHC

View more →

(m)

Statistics

View more →

Retained observations as of 2026-11-11; financial period ending 31 Mar 2026.

Forward P/E
(m)
PEG ratio · 5-year expected
(m)
Shares held by insiders
(m)
Insider transactions · change (%)
(m)
Shares held by institutions
(m)
Institutional transactions · change (%)
(m)
Diluted EPS · 12 month
(m)
EPS estimate · next quarter
(m)
EPS estimate · next year
(m)
EPS growth · current annual estimate
(m)
EPS growth · next annual estimate
(m)
EPS growth · next 5 years expected
(m)
EPS growth · past 3 years annualized
(m)
EPS growth · past 5 years annualized
(m)
EPS change · 12 months vs prior year
(m)
EPS change · latest quarter vs previous quarter
(m)
Latest earnings report date
(m)
EPS surprise · latest reported quarter
(m)
Net income · 12 month
$1.91B
Profit margin
9.10%
Return on assets · 12 month
5.40%
Named executive and board stock awards · latest fiscal year
(m)
Index membership
(m)
Employees
(m)
IPO date
(m)
Options available
(m)
Shortable
(m)
Analyst recommendation
(m)
Analyst target price
(m)
Price volatility · week
(m)
Price volatility · month
(m)
Average true range · 14 sessions
(m)
Relative strength index · 14 sessions
(m)
Relative volume
(m)
Average daily volume
3.62M
Latest session volume
(m)
Last session value
(m)
30 days ago session value
(m)
1 year ago session value
(m)
Number of trades
(m)
Total return · week
0.33%*
Total return · month
-7.30%*
Total return · quarter
2.26%*
Total return · half year
-3.87%*
Total return · year to date
-18.82%*
Total return · 1 year
-8.87%*
Total return · 3 years
-1.78%*
Total return · 5 years
(m)
Market cap
(m)
Book value per share · latest quarter
(m)
Price / cash · latest quarter
(m)
Enterprise value
(m)
Enterprise value / revenue
(m)
Enterprise value / EBITDA
(m)
Dividend · 12 months per share
(m)
Dividend ex-date
(m)
Next dividend ex-date
(m)
Next dividend amount per share
(m)
Dividend growth · 3 years annualized
(m)
Dividend growth · 5 years annualized
(m)
Revenue · 12 month
$20.98B
Revenue growth · past 3 years annualized
(m)
Revenue growth · past 5 years annualized
(m)
Revenue change · 12 months vs prior year
(m)
Revenue change · latest quarter vs previous quarter
(m)
Revenue surprise · latest reported quarter
(m)
Levered free cash flow · 12 month
(m)
Debt / equity · latest quarter
(m)
Long-term debt / equity · latest quarter
94.95%*
Return on equity · 12 month
(m)
Return on invested capital · 12 months
(m)
Previous close
(m)
Latest closing price
(m)
Latest session change (%)
(m)
52-week high
(m)
52-week low
(m)
Price vs 20-session moving average
(m)
Price vs 50-session moving average
(m)
Price vs 200-session moving average
(m)
Float shares
(m)
Short float (%)
(m)
Short ratio (days to cover)
(m)
Short interest (shares)
(m)

Five-year projected P/E and P/S repeat the preceding five-year EPS and revenue CAGR, holding current price and market cap constant. Hover a calculated row for its formula. Net assets = assets − debt − payables − deferred revenue − obligations due within 1 year − obligations due after 1 year.

Holders breakdown

View more →
BreakdownOwnership
(m)Shares held by all insiders
(m)Shares held by institutions
(m)Float held by institutions
(m)Institutions holding shares

Other holders

(m)

View more →

Insider holders

(m)

View more →

Top institutional holders

(m)

View more →

Top mutual fund holders

(m)

View more →

GE HEALTHCARE TECHNOLOGIES INC. Overview

View more →

(m)

(m)

SEC CIK
1932393
Industry (SIC)
3844 X-Ray Apparatus & Tubes & Related Irradiation Apparatus
Country of operation
United States
Business address
500 WEST MONROE STREET, CHICAGO, Illinois, 60661, United States
Fiscal year end
1231
Phone
833-735-1139